• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Respiratory syncytial virus market.

作者信息

Storey Shane

出版信息

Nat Rev Drug Discov. 2010 Jan;9(1):15-6. doi: 10.1038/nrd3075.

DOI:10.1038/nrd3075
PMID:20043025
Abstract
摘要

相似文献

1
Respiratory syncytial virus market.呼吸道合胞病毒市场。
Nat Rev Drug Discov. 2010 Jan;9(1):15-6. doi: 10.1038/nrd3075.
2
RSV disease--is there a role for prevention?呼吸道合胞病毒疾病——预防有作用吗？
Respir Med. 2001 Mar;95(3):170-2. doi: 10.1053/rmed.2000.1018.
3
Palivizumab (synagis): counting "costs" and values.
Pediatrics. 2000 Nov;106(5):1168-9. doi: 10.1542/peds.106.5.1168.
4
Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner?呼吸道合胞病毒的治疗与预防：我们终于迎来转机了吗？
Eur Respir J. 2011 Aug;38(2):246-7. doi: 10.1183/09031936.00012011.
5
Prevention of respiratory syncytial virus infection in infants.婴儿呼吸道合胞病毒感染的预防
BMJ. 2004 May 1;328(7447):1026-7. doi: 10.1136/bmj.328.7447.1026.
6
Therapies to Decrease Severe Respiratory Syncytial Virus Illness.降低严重呼吸道合胞病毒疾病的疗法。
JAMA. 2024 Jun 25;331(24):2127-2128. doi: 10.1001/jama.2024.7406.
7
[Prevention of respiratory syncytial virus infections with palivizumab].[使用帕利珠单抗预防呼吸道合胞病毒感染]
Tidsskr Nor Laegeforen. 2003 Apr 3;123(7):941-3.
8
New strategies for control of respiratory syncytial virus infection.控制呼吸道合胞病毒感染的新策略。
Curr Opin Infect Dis. 2008 Dec;21(6):639-43. doi: 10.1097/QCO.0b013e3283184245.
9
Respiratory syncytial virus: old challenges and new approaches.呼吸道合胞病毒：旧挑战与新方法
Pediatr Ann. 2005 Jan;34(1):62-8. doi: 10.3928/0090-4481-20050101-14.
10
Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis.
Curr Med Res Opin. 2009 Jul;25(7):1631-2; author reply 1632-3. doi: 10.1185/03007990902993415.

引用本文的文献

1
Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.人类呼吸道合胞病毒生物学：免疫反应及抗病毒机制的当前观点
Virus Res. 2024 Dec;350:199483. doi: 10.1016/j.virusres.2024.199483. Epub 2024 Oct 18.
2
Respiratory Syncytial Virus Infection: Treatments and Clinical Management.呼吸道合胞病毒感染：治疗与临床管理
Vaccines (Basel). 2023 Feb 20;11(2):491. doi: 10.3390/vaccines11020491.
3
Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018.

本文引用的文献

1
Motavizumab for the prevention of respiratory syncytial virus infection in infants.莫他维izumab预防婴儿呼吸道合胞病毒感染
Expert Opin Biol Ther. 2009 Oct;9(10):1335-45. doi: 10.1517/14712590903287499.
2
Challenges in developing a pediatric RSV vaccine.开发儿童呼吸道合胞病毒疫苗面临的挑战。
Hum Vaccin. 2009 Sep;5(9):582-91. doi: 10.4161/hv.9131. Epub 2009 Sep 28.
3
Emerging drugs for respiratory syncytial virus infection.用于呼吸道合胞病毒感染的新型药物
中国 2009-2018 年 A、B 型呼吸道合胞病毒的进化动态。
Arch Virol. 2021 Sep;166(9):2407-2418. doi: 10.1007/s00705-021-05139-2. Epub 2021 Jun 15.
4
Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection.发现3,3'-螺[氮杂环丁烷]-2-氧代吲哚啉衍生物作为治疗呼吸道合胞病毒感染的融合抑制剂
ACS Med Chem Lett. 2018 Jan 10;9(2):94-97. doi: 10.1021/acsmedchemlett.7b00418. eCollection 2018 Feb 8.
5
Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus.人呼吸道合胞病毒对单核吞噬细胞系统的功能损害
Front Immunol. 2017 Nov 27;8:1643. doi: 10.3389/fimmu.2017.01643. eCollection 2017.
6
Transient Depletion of CD169 Cells Contributes to Impaired Early Protection and Effector CD8 T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection.CD169细胞的短暂耗竭导致早期保护受损以及效应性CD8 T细胞募集受损，从而影响针对黏膜呼吸道合胞病毒感染的免疫反应。
Front Immunol. 2017 Jul 13;8:819. doi: 10.3389/fimmu.2017.00819. eCollection 2017.
7
Evolution and Transmission of Respiratory Syncytial Group A (RSV-A) Viruses in Guangdong, China 2008-2015.2008 - 2015年中国广东省A组呼吸道合胞病毒（RSV - A）的进化与传播
Front Microbiol. 2016 Aug 15;7:1263. doi: 10.3389/fmicb.2016.01263. eCollection 2016.
8
Human Respiratory Syncytial Virus: Infection and Pathology.人呼吸道合胞病毒：感染与病理学
Semin Respir Crit Care Med. 2016 Aug;37(4):522-37. doi: 10.1055/s-0036-1584799. Epub 2016 Aug 3.
9
The present state of the art in expression, production and characterization of monoclonal antibodies.单克隆抗体的表达、生产及特性鉴定的当前技术水平。
Mol Divers. 2016 Feb;20(1):255-70. doi: 10.1007/s11030-015-9625-z. Epub 2015 Aug 25.
10
Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection.帕利珠单抗注射方案抗呼吸道合胞病毒感染的疗效及优化
JAMA Pediatr. 2015 Apr;169(4):341-8. doi: 10.1001/jamapediatrics.2014.3804.
Expert Opin Emerg Drugs. 2009 Jun;14(2):207-17. doi: 10.1517/14728210902946399.
4
Impact of RSV: implications for managed care.呼吸道合胞病毒的影响：对管理式医疗的启示
Manag Care. 2009 Jan;18(1 Suppl 2):2-7.
5
RSV infection in the adult population.
Manag Care. 2008 Nov;17(11 Suppl 12):13-5, discussion 18-9.
6
Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria.帕利珠单抗对奥地利高危儿童呼吸道合胞病毒感染的成本效益分析
Clin Ther. 2008 Apr;30(4):749-60. doi: 10.1016/j.clinthera.2008.03.014.
7
Respiratory syncytial virus infection in adults.成人呼吸道合胞病毒感染
Curr Opin Pulm Med. 2008 May;14(3):235-40. doi: 10.1097/MCP.0b013e3282f79651.
8
Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab.呼吸道合胞病毒感染的免疫预防：从呼吸道合胞病毒免疫球蛋白静脉注射剂发展到帕利珠单抗和莫他珠单抗。
Curr Top Microbiol Immunol. 2008;317:103-23. doi: 10.1007/978-3-540-72146-8_4.
9
1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate.1,4-苯二氮䓬类化合物作为呼吸道合胞病毒的抑制剂。临床候选药物的鉴定。
J Med Chem. 2007 Apr 5;50(7):1685-92. doi: 10.1021/jm060747l. Epub 2007 Mar 7.
10
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).为增强与新生儿Fc受体（FcRn）的结合而改造的人IgG1的特性。
J Biol Chem. 2006 Aug 18;281(33):23514-24. doi: 10.1074/jbc.M604292200. Epub 2006 Jun 21.